Document Detail


Pharmaceutical metabolic down-regulation by protein synthesis inhibition in a conscious rat model.
MedLine Citation:
PMID:  17292527     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pharmaceutically induced metabolic down-regulation may be a useful therapeutic adjunct when tissue oxygen supply is restricted. We hypothesized that protein synthesis inhibition in a non-hibernating species should lower oxygen demand, resulting in aerobic metabolic rate depression at the whole animal level. We compared metabolic responses and measures of systemic oxygenation of conscious catheterized rats given either protein synthesis inhibition (PSI) agents or carrier controls (normal saline and DMSO). Core temperature was measured by implanted transmitters, and VO2 was determined in an open flow-through metabolic chamber at 25 degrees C. Mean arterial pressure MAP and heart rate HR were determined from arterial pressure transducer tracings; arterial blood gases and lactate were sampled every 15 min. PSI rats exhibited an immediate transient decline in VO2, followed by a secondary decline to new resting levels; VO2 for the first hour was significantly lower than that for rats receiving DMSO vehicle. Unlike controls, PSI rats showed an overall 3.5 degrees C decline in core temperature, coupled with increased arterial lactate. There were no differences in MAP and HR of PSI rats compared to controls. Although hypothermic response to toxic agents typical of rodents cannot be ruled out completely, the mild hypothermia and reduced VO2 exhibited by PSI rats may be partially attributed to the action of protein synthesis agents.
Authors:
Penny S Reynolds; R Wayne Barbee; Kevin R Ward
Related Documents :
15189347 - 3,4-methylenedioxymethamphetamine increases interleukin-1beta levels and activates micr...
6133687 - Long scotophase acclimation increases free urinary catecholamine content in the rat.
7341537 - Body composition in a rat model of moderate uremia.
2576727 - Thermal salivation in rats, anesthetized with barbiturates, chloralose, urethane and ke...
3927317 - Prostaglandin synthesis from endogenous and exogenous arachidonic acid in the rat uteru...
18626997 - Comparison of metabolite profiles generated in aroclor-induced rat liver and human live...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2007-02-09
Journal Detail:
Title:  Resuscitation     Volume:  73     ISSN:  0300-9572     ISO Abbreviation:  Resuscitation     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-21     Completed Date:  2007-08-17     Revised Date:  2009-08-25    
Medline Journal Info:
Nlm Unique ID:  0332173     Medline TA:  Resuscitation     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  446-58     Citation Subset:  IM    
Affiliation:
Department of Emergency Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0401, USA. psreynolds@vcu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anisomycin / pharmacology*
Blood Gas Analysis
Body Temperature / drug effects*
Consciousness / drug effects
Heart Rate / drug effects
Male
Motor Activity / drug effects
Oxygen Consumption / drug effects*
Protein Synthesis Inhibitors / pharmacology*
Puromycin / pharmacology*
Rats
Rats, Sprague-Dawley
Respiration / drug effects
Chemical
Reg. No./Substance:
0/Protein Synthesis Inhibitors; 22862-76-6/Anisomycin; 53-79-2/Puromycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A pregnant woman with acute myocardial infarction due to coronary artery dissection: pre-hospital an...
Next Document:  'Blind' transfusion of blood products in exsanguinating trauma patients.